ACTG — Acacia Research Share Price
Last Trade - 00:00- $269.56m
- -$79.14m
- $29.78m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 152.7 | 65.4 | 131.51 | 11.25 | 29.78 | 17.05 | 19 | -24.94% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Acacia Research Corporation, through its subsidiaries, invests in, licenses and enforces patented technologies. The Company's operating subsidiaries partner with inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. The Company's operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. The Company's operating subsidiaries own or control the rights to multiple patent portfolios, which include the United States patents and certain foreign counterparts, covering technologies used in a range of industries.
Directors
- Maureen O'Connell (59)
- Alfred Tobia PRE (56)
- Clifford Press CEO (66)
- Richard Rosenstein (56)
- Jason Soncini (44)
- Marc Booth (63)
- Isaac Kohlberg (69)
- Jonathan Sagal (39)
- Katharine Wolanyk (57)
- Last Annual
- December 31st, 2020
- Last Interim
- December 31st, 2020
- Incorporated
- October 8th, 1999
- Public Since
- March 17th, 1980
- No. of Shareholders
- 63
- No. of Employees
- 20
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 49,279,453
- Address
- 767 3Rd Avenue, Suite 602, NEW YORK, 10017
- Web
- http://acaciaresearch.com/
- Phone
- +1 9494808300
- Contact
- Rob Fink
- Auditors
- Grant Thornton LLP
Latest News for ACTG
Upcoming events for ACTG
Q3 2021 Acacia Research Corp Earnings Release
Similar to ACTG
CINTAS ORD
NASDAQ Global Select Market
CONCENTRIX ORD
NASDAQ Global Select Market
CRA INTERNATIONAL ORD
NASDAQ Global Select Market
EXLSERVICE HOLDINGS ORD
NASDAQ Global Select Market
EXPONENT ORD
NASDAQ Global Select Market
FAQ
As of Today at 19:54 UTC, shares in Acacia Research are trading at $5.47. This share price information is delayed by 15 minutes.
Shares in Acacia Research last closed at $5.47 and the price had moved by +35.73% over the past 365 days. In terms of relative price strength the Acacia Research share price has outperformed the S&P500 Index by +2.98% over the past year.
The overall consensus recommendation for Acacia Research is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Acacia Research does not currently pay a dividend.
Acacia Research does not currently pay a dividend.
Acacia Research does not currently pay a dividend.
To buy shares in Acacia Research you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $5.47, shares in Acacia Research had a market capitalisation of $269.56m.
Here are the trading details for Acacia Research:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: ACTG
Based on an overall assessment of its quality, value and momentum Acacia Research is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Acacia Research is $8.00. That is 46.25% above the last closing price of $5.47.
Analysts covering Acacia Research currently have a consensus Earnings Per Share (EPS) forecast of -$3.11 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Acacia Research. Over the past six months, its share price has underperformed the S&P500 Index by -40.14%.
As of the last closing price of $5.47, shares in Acacia Research were trading -1.75% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for Acacia Research.
Acacia Research's management team is headed by:
- Maureen O'Connell -
- Alfred Tobia - PRE
- Clifford Press - CEO
- Richard Rosenstein -
- Jason Soncini -
- Marc Booth -
- Isaac Kohlberg -
- Jonathan Sagal -
- Katharine Wolanyk -
We do not have data on Acacia Research's shareholders